| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €24,6906 | +3,79% | €1,50B | €47,75K | |
SGRY Surgery Partners, Inc. Common Stock | €11,9276 | +2,73% | €1,50B | €132,68K | |
GAB The Gabelli Equity Trust Inc. | €4,8169 | -0,09% | €1,50B | €242,84K | |
HURN Huron Consulting Group Inc. | €92,9200 | +3,17% | €1,49B | €8,96K | |
ENVX Enovix Corporation Common Stock | €7,0333 | -0,56% | €1,49B | €1,40M | |
PAYO Payoneer Global Inc. Common Stock | €4,5076 | +3,05% | €1,49B | €500,26K | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8008 | -0,10% | €1,49B | €30,37K | |
STGW Stagwell Inc. Class A Common Stock | €5,8482 | +3,26% | €1,49B | €79,19K | |
CASH Pathward Financial, Inc. Common Stock | €68,2312 | +2,13% | €1,49B | €12,81K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,3824 | -2,40% | €1,49B | €2,70M | |
STRA Strategic Education, Inc. Common Stock | €69,9638 | +2,99% | €1,49B | €27,87K | |
CAPR Capricor Therapeutics Inc | €24,2222 | +1,97% | €1,49B | €67,30K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,8637 | +3,30% | €1,48B | €1,34K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,5473 | +7,23% | €1,48B | €1,40M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €24,3305 | +13,29% | €1,48B | €161,66K | |
